Abstract
This paper aims to investigate the role of known risk factors in explaining educational differences in breast cancer incidence. Analyses were based on the European Prospective Investigation into Cancer and Nutrition, and included 242,095 women, 433 in situ and 4,469 invasive breast cancers. Reproductive history (age at first full term pregnancy and parity), exposure to endogenous and exogenous hormones, height, and health behaviours were accounted for in the analyses. Relative indices of inequality (RII) for education were estimated using Cox regression models. Higher invasive breast cancer risk was found among women with higher education (RII=1.22: 1.09,1.37). This association was not observed among nulliparous women (RII=1.13: 0.84,1.52). Inequalities in breast cancer incidence decreased substantially after adjusting for reproductive history (RII=1.11: 0.98,1.25), most of the association being explained by age at first full term pregnancy. Each other risk factor explained a small additional part of inequalities in breast cancer incidence. Height contributed most of these factors. When all known risk factors were adjusted for, no association remained between education and invasive breast cancer risk. Inequalities in incidence were more pronounced for in situ breast cancers and remained after adjustment for all known risk factors (RII=1.61: 1.07,2.41), especially among nulliparous women.
Keywords: breast neoplasms, incidence, education, reproductive history, risk factors
Breast cancer shows a specific pattern with regards to socioeconomic inequalities: higher incidence rates are found among women with higher socioeconomic status [1]. Considering possible risk factors as potential mediators between education and breast cancer incidence helps to better understand the mechanisms of socioeconomic inequalities [2]. Studies generally found that age at first birth and parity (number of full term pregnancies) only in part accounted for the socioeconomic inequalities in breast cancer incidence because of a higher age at first birth and a lower parity among women with higher socioeconomic status [3–7]. Many other risk factors (e.g. hormonal, behavioural or anthropometric) are involved in breast cancer carcinogenesis [8, 9]. As few studies investigated socioeconomic inequalities in breast cancer incidence in relation with risk factors other than age at first birth or parity, it is uncertain how much these other risk factors contribute to socioeconomic inequalities in breast cancer risk [4, 5, 10]. Consequently, it still remains unclear whether a socially stratified distribution of known risk factors totally accounts for the socioeconomic inequalities observed in breast cancer incidence, and which risk factors, in addition to reproductive history, are involved in the mechanisms leading to socioeconomic inequalities in breast cancer incidence.
Based on the natural history of breast cancer, several subgroups of women can be distinguished. Of particular interest are women who never had children, because they have not been exposed to the two main protective risk factors (age at first birth and parity). In addition, it is of interest to distinguish between pre and postmenopausal women, and between women experiencing an invasive cancer and those with an in situ breast cancer. Because the risk factors involved [9, 11, 12] and the magnitude of inequalities differ between these groups [5, 7, 10, 13], analyses within these different subgroups may also provide further insights into the causes of socioeconomic inequalities in breast cancer incidence. However, previous studies rarely reported on such stratified analyses.
The European Prospective Investigation into Cancer and Nutrition (EPIC) is a large prospective cohort including several European countries with detailed information on numerous risk factors. Using the EPIC study, we aim to investigate the role of known breast cancer risk factors in explaining educational differences in breast cancer incidence. The large size of the cohort gave us the unique opportunity to perform analyses in several sub-groups and by cancer type (invasive and in situ).
MATERIALS AND METHODS
Population
The EPIC cohort is a multi centre prospective cohort conducted in 23 centres in 10 European countries (France, Italy (Florence, Varese, Ragusa, Turin, and Naples), Spain (Asturias, Granada, Murcia, Navarra, and San Sebastian), the UK (Cambridge, Oxford), the Netherlands (Utrecht, Bilthoven), Greece, Germany (Postdam, Heidelberg), Sweden (Malmö, Umea), Denmark (Copenhagen, Aarhus), and Norway) [14, 15]. The study started at the beginning of the 1990s and included about 350,000 women mostly aged between 40–65 years. In most centres subjects were recruited from the general population in a given geographical area (country, region, or city). The French cohort consists of members of the health insurance program for school and university employees, part of the Spanish and Italian centres include blood donors, the Utrecht cohort is based on participants in a mammography screening program, and the cohort in Florence also includes screening program participants. In Oxford, most of the cohort consists of ‘health conscious’ subjects (vegetarian volunteers or healthy eaters). Dietary and lifestyle questionnaires were collected for all subjects at the time of enrolment in the cohort using questionnaires specific to each country.
Women with prevalent cancer at baseline (except non-melanoma skin cancer) were excluded from the cohort (n=19,953). We excluded women with a ratio for energy intake versus energy expenditure in the top and bottom 1% (n=6,796), women with missing information on education (n=14,026), main dietary variables (n=2,441), age at first full term pregnancy or number of full term pregnancies (n=17,785), women who never had menarche (n=1), and women with missing information on date of diagnosis for a cancer prior to the breast cancer (n=3). The date of diagnosis was available for all breast cancer cases. We excluded women from one Swedish centre (Umea) since information on parity and age at first full term pregnancy was missing for most of the women (n=3,592). Compared to other cohorts, the French cohort was a demographically homogeneous population with most women concentrated in the two highest educational levels, leaving little room for studying educational inequalities in this group. Moreover, because of its size, including this cohort would impact the results for the whole EPIC cohort. For these reasons, we decided to exclude the French cohort (n=59,248).
End points
Incident cases were identified by population-based cancer registries in Denmark, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom or by active follow-up (Germany, and Greece). For the present analysis, the end of the follow-up period occurred between December 2002 and December 2006. The mean follow-up was 8.4 years. The outcome variable was first primary incident breast cancer. During this follow-up, 4,910 breast cancer cases (invasive n=4,469, in situ n=433, uncertain n=8) were reported. Cancer incidence data were coded according to ICD-O-2. Participants who developed a different primary cancer prior to breast cancer were censored at the date of diagnosis of the earlier cancer. Breast cancers with uncertain histology were excluded. We separately analysed invasive and in situ breast cancers.
Statistical analyses
Analyses were conducted with Cox regression models, stratified on center and age at baseline in 1 year age categories with age as time variable. We computed hazard ratios (HR) using women with primary education or less as reference category. We also computed relative indices of inequality (RII). The calculation of the RII is based on a relative measure of education. Each individual is assigned a fractional rank (from 0 to 1) corresponding to the mean proportion of the population with a lower level of education, using the mean rank for ties. For instance, if the lowest educational group comprises 20% of the population, each individual from this group is assigned a value of 0.20/2=0.10. If the next lowest educational group comprises 30% of the population, each individual from this group is assigned a value of 0.20+0.30/2=0.35. The RII is then computed with a Cox regression model using this ranked variable as independent variable and breast cancer as dependent variable. Thus, the RII expresses inequality within the whole socioeconomic continuum. It can be interpreted as the ratio of the expected breast cancer risk between the highest (100th percentile rank) and the lowest (0th percentile rank) educated woman in the study population. Thus, a RII higher than 1 means that breast cancer risk increases with education and is higher among higher educated women. As it takes into account the size and relative position of each educational group, the RII minimizes problems due to differences in distribution of educational degrees across countries participating in the EPIC study. This index is well established and was adapted to compare populations with different educational distributions [16]. This ranked variable was computed by age category, and centre except for the health conscious Oxford cohort, which was a highly selected population. We therefore assigned to these women the rank scores from the Cambridge cohort.
Information about the highest educational level was collected using a questionnaire specific to each country. This allowed taking into account the specificities of each educational system. Each educational classification was then converted into a common classification, which reduces inconsistencies between the different educational systems. Education was categorized in four categories: primary education or less, vocational secondary education, other secondary education, university or vocational post-secondary education. Risk factors were considered as potential intermediate variables that may explain the association observed between education and breast cancer risk. The following variables were included: age at first full term pregnancy (nulliparous, <20, 20–24, 25–29, 30–34, 35–39, 40+), parity (number of full term pregnancies: nulliparous, 1, 2, 3, 4, 5+), age at menarche (<12, 12–14, 15+, missing), ever use of oral contraceptive (yes, no, missing), duration of use of oral contraceptive (never, <=1 year, 2–4, 5–9, 10–14, 15+, missing), ever use of hormonal replacement therapy (HRT) (yes, no, missing), duration of use of HRT (no treatment, <=1 year, 2–4, 5–9, 10+, missing), ever breastfeeding (nulliparous, yes, no, missing), duration of breastfeeding (nulliparous, no breastfeeding, 0–6 months, 6–12, 12+, missing), menopausal status at recruitment (premenopausal, postmenopausal, perimenopausal, surgical postmenopause), age at menopause (post-menopausal with age at menopause <50 years, post-menopausal with age at menopause 50+ years, post-menopausal with age at menopause missing), height (continuous), body mass index (BMI) (<18.5, 18.5–24, 25–29, 30+), alcohol consumption (g/d during 12 months prior to recruitment) (continuous), total physical activity (work and leisure) (inactive, moderately inactive, moderately active, active, missing) [17]. We also coded alcohol consumption as a categorical variable (abstainers and quartiles among drinkers). The results were close to those obtained with alcohol entered as a continuous variable and therefore only the latter was used. When introduced simultaneously, menopausal status and age at menopause were combined into one single categorical variable coded as follows: premenopausal, perimenopausal, surgical postmenopause, postmenopausal with age at menopause <50, postmenopausal with age at menopause 50+, postmenopausal with age at menopause missing. Also, when adjusted for simultaneously, age at first full term pregnancy and number of full term pregnancies were combined into one single categorical variable coded as follows: nulliparous, one pregnancy before 20, one pregnancy between 20 and 24, one pregnancy between 25 and 29, one pregnancy between 30 and 34, one pregnancy between 35 and 39, one pregnancy after 40, two pregnancies and the first before 20, two pregnancies and the first between 20 and 24…
We first adjusted for age at first full term pregnancy and parity (separately and simultaneously). Then we introduced, in addition to the two previous risk factors, each other risk factor separately and successively. We finally considered a model including all risk factors together. We conducted analyses among all women and stratified among nulliparous and parous women, and among premenopausal and postmenopausal women (excluding surgical postmenopausal women). These analyses were conducted separately for invasive and in situ breast cancers. Because cancer registration practices, preventive measures, medical services and screening practices differed across EPIC centres, we conducted a heterogeneity analysis by country.
RESULTS
Most of the 242,095 women belong to the two lowest education groups (Table 1). The distribution across education was similar overall and in parous or postmenopausal women. The level of education was higher among nulliparous and premenopausal women. The distribution across education differed for invasive and in situ breast cancers. Comparatively more in situ breast cancers occurred among women with college or university education. Women with a lower education showed an older age at menarche, less use of oral contraceptives, a younger age at first full term pregnancy, a higher parity, a greater BMI, a higher level of physical activity, and a lower consumption of alcohol than women with a higher education (Table 2). Age at menopause increased slightly with increasing education.
Table 1.
All | Education
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Primary | Vocational secondary | Other secondary | University or post-secondary vocational | ||||||
N | N | % | N | % | N | % | N | % | |
All women | 242,095 | 83,303 | 34 | 68,872 | 29 | 41,905 | 17 | 48,015 | 20 |
Invasive breast cancers | 4,469 | 1,523 | 34 | 1,381 | 31 | 727 | 16 | 838 | 19 |
In situ breast cancers | 433 | 139 | 32 | 107 | 25 | 70 | 16 | 117 | 27 |
Parous women | 201,668 | 76,103 | 38 | 58,808 | 29 | 33,414 | 17 | 33,343 | 16 |
Invasive breast cancers | 3,805 | 1,356 | 36 | 1,186 | 31 | 613 | 16 | 650 | 17 |
In situ breast cancers | 370 | 128 | 35 | 95 | 26 | 61 | 16 | 86 | 23 |
Nulliparous women | 40,427 | 7,200 | 18 | 10,064 | 25 | 8,491 | 21 | 14,672 | 36 |
Invasive breast cancers | 664 | 167 | 25 | 195 | 30 | 114 | 17 | 188 | 28 |
In situ breast cancers | 63 | 11 | 18 | 12 | 19 | 9 | 14 | 31 | 49 |
Premenopausal womena | 90,244 | 21,060 | 23 | 24,157 | 27 | 19,191 | 21 | 25,836 | 29 |
Invasive breast cancers | 1,067 | 276 | 26 | 272 | 25 | 230 | 22 | 289 | 27 |
In situ breast cancers | 110 | 23 | 21 | 27 | 25 | 20 | 18 | 40 | 36 |
Postmenopausal womena | 102,721 | 43,319 | 45 | 28,959 | 28 | 13,852 | 14 | 13,591 | 13 |
Invasive breast cancers | 2,389 | 947 | 40 | 756 | 32 | 323 | 13 | 363 | 15 |
In situ breast cancers | 230 | 93 | 40 | 54 | 23 | 38 | 17 | 45 | 20 |
Some women are perimenopaused or have surgical menopause.
Table 2.
All women | Education
|
||||||
---|---|---|---|---|---|---|---|
Primary | Vocational secondary | Other secondary | University or post-secondary vocational | ||||
Mean (±SD) | Mean (±SD) | Mean (±SD) | Mean (±SD) | Mean (±SD) | |||
Age at recruitment | 50.3 (±10.2) | 54.1 (±8.9) | 50.2 (±9.5) | 47.7 (±10.2) | 46.2 (±10.7) | ||
Number of full term pregnancies | 2.3 (±1.0) | 2.5 (±1.2) | 2.2 (±0.9) | 2.2 (±1.0) | 2.1 (±0.9) | ||
Age at first full term pregnancy | 24.8 (±4.4) | 23.7 (±4.2) | 24.3 (±4.2) | 25.7 (±4.2) | 27.3 (±4.6) | ||
Age at menopausea | 48.7 (±4.7) | 48.6 (±4.8) | 48.8 (±4.7) | 48.8 (±4.7) | 49.0 (±4.6) | ||
Height (cm) | 162.5 (±7.0) | 159.1 (±6.8) | 164.0 (±6.2) | 164.1 (±6.6) | 164.5 (±6.4) | ||
Median (IQ range) | Median (IQ range) | Median (IQ range) | Median (IQ range) | Median (IQ range) | |||
Alcohol consumption in g/day | 3.2 (10.1) | 1.4 (7.4) | 4.1 (9.9) | 3.7 (10.2) | 6.2 (11.5) | ||
NI | NIS | % | % | % | % | % | |
Duration of breast feeding | |||||||
Nulliparous | 664 | 63 | 16.7 | 8.6 | 14.6 | 20.2 | 30.6 |
Parous: Never breastfed | 460 | 53 | 9.7 | 11.2 | 10.8 | 8.8 | 6.1 |
Parous: 0–6 months | 1376 | 135 | 28.4 | 30.0 | 32.4 | 24.6 | 23.1 |
Parous: 6–12 months | 836 | 93 | 18.7 | 21.0 | 19.0 | 17.6 | 15.6 |
Parous: >12 months | 957 | 72 | 22.9 | 26.5 | 18.7 | 24.0 | 21.7 |
Parous: Missing information | 176 | 17 | 3.6 | 2.7 | 4.5 | 4.8 | 2.9 |
Age at menarche | |||||||
<12 | 577 | 67 | 14.1 | 13.9 | 12.6 | 15.3 | 15.9 |
12–14 | 3032 | 294 | 67.8 | 65.7 | 67.5 | 69.6 | 70.0 |
>14 | 788 | 63 | 16.9 | 19.4 | 18.3 | 14.0 | 13.2 |
Missing | 72 | 9 | 1.2 | 1.1 | 1.6 | 1.1 | 0.9 |
Duration of use of oral contraceptive | |||||||
Never | 1928 | 188 | 41.4 | 60.6 | 31.7 | 34.6 | 28.0 |
1 year or less | 473 | 42 | 11.0 | 10.6 | 10.4 | 12.5 | 11.2 |
2–4 years | 567 | 49 | 13.2 | 9.4 | 14.2 | 15.4 | 16.3 |
5–9 years | 501 | 48 | 12.2 | 7.2 | 14.1 | 13.4 | 17.0 |
10–14 years | 381 | 44 | 8.6 | 5.1 | 11.1 | 8.6 | 11.3 |
15+ years | 403 | 40 | 7.7 | 4.7 | 11.1 | 6.3 | 9.0 |
Missing | 216 | 22 | 5.9 | 2.4 | 7.4 | 9.2 | 7.2 |
Duration of use of hormonal replacement therapy | |||||||
No treatment | 2615 | 257 | 70.7 | 72.9 | 63.2 | 76.4 | 72.9 |
1 year or less | 361 | 36 | 6.8 | 7.3 | 7.5 | 6.0 | 5.4 |
2–4 years | 408 | 40 | 6.6 | 5.5 | 8.6 | 6.3 | 5.9 |
5–9 years | 357 | 26 | 4.4 | 3.7 | 6.2 | 3.6 | 3.7 |
10+ years | 225 | 18 | 2.4 | 2.4 | 3.5 | 1.7 | 1.5 |
Missing | 503 | 56 | 9.1 | 8.2 | 11.1 | 5.9 | 10.6 |
BMI (kg/m2) | |||||||
<18.5 | 47 | 4 | 1.5 | 0.7 | 1.5 | 1.9 | 2.5 |
18.5–24 | 2261 | 227 | 51.6 | 33.9 | 55.9 | 61.7 | 67.3 |
25–29 | 1501 | 143 | 31.9 | 39.7 | 31.1 | 27.6 | 23.4 |
30+ | 660 | 59 | 15.0 | 25.7 | 11.5 | 8.8 | 6.8 |
Total physical activity | |||||||
Inactive | 612 | 58 | 11.4 | 4.0 | 13.9 | 12.2 | 20.1 |
Moderately inactive | 1071 | 102 | 21.6 | 17.4 | 22.1 | 20.3 | 29.5 |
Moderately active | 1826 | 200 | 41.6 | 57.4 | 34.0 | 33.6 | 31.9 |
Active | 444 | 66 | 9.7 | 10.9 | 10.2 | 7.9 | 8.3 |
Missing | 516 | 7 | 15.7 | 10.3 | 19.8 | 26.0 | 10.2 |
BMI body mass index; IQ range inter-quartile range; NI=number of invasive breast cancers; NIS=number of in situ breast cancers SD standard deviation;
Among postmenopausal women
The relative risk of invasive breast cancer increased as education increased (RII=1.22: 95% CI 1.09, 1.37) (Table 3). Inequalities in breast cancer incidence as measured with the HRs or the RIIs were similar overall and in parous and postmenopausal women. Inequalities were slightly larger among premenopausal women. Among nulliparous women, there was no clear gradient with education: the risk of cancer was nevertheless slightly lower among women with primary education when compared with all other women.
Table 3.
Model adjusted for | RII | 95% CI | Primary | Vocational secondary | Other secondary | University or post- seconday vocational | |||
---|---|---|---|---|---|---|---|---|---|
HR | HR | 95% CI | HR | 95% CI | HR | 95% CI | |||
All women | |||||||||
Model 0: Stratified for age and centera | 1.22 | 1.09, 1.37 | 1 | 1.09 | 1.01, 1.18 | 1.12 | 1.02, 1.23 | 1.19 | 1.08, 1.31 |
M0 + Parity | 1.18 | 1.05, 1.33 | 1 | 1.08 | 0.99, 1.17 | 1.10 | 1.00, 1.21 | 1.16 | 1.06, 1.27 |
M0 + Age at first full term pregnancy | 1.10 | 0.98, 1.24 | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.17 | 1.10 | 1.00, 1.21* |
M0 + Reproductive historyb | 1.11 | 0.98, 1.25 | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.18 | 1.10 | 1.00, 1.21 |
M0 + All risk factorsc | 0.99 | 0.87, 1.12 | 1 | 1.01 | 0.93, 1.10 | 1.00 | 0.91, 1.11 | 1.01 | 0.91, 1.12 |
Nulliparous women | |||||||||
Model 0: Stratified for age and centera | 1.13 | 0.84, 1.52 | 1 | 1.15 | 0.92, 1.44 | 1.10 | 0.85, 1.42 | 1.10 | 0.86, 1.38 |
M0 + All risk factorsd | 1.00 | 0.73, 1.37 | 1 | 1.10 | 0.87, 1.38 | 1.02 | 0.78, 1.33 | 1.00 | 0.78, 1.27 |
Parous women | |||||||||
Model 0: Stratified for age and centera | 1.22 | 1.07, 1.38 | 1 | 1.08 | 0.99, 1.18 | 1.12 | 1.01, 1.24 | 1.20 | 1.08, 1.33 |
M0 + Parity | 1.20 | 1.06, 1.36 | 1 | 1.07 | 0.98, 1.17 | 1.11 | 1.00, 1.13 | 1.19 | 1.07, 1.32 |
M0 + Age at first full term pregnancy | 1.11 | 0.97, 1.26 | 1 | 1.06 | 0.97, 1.15 | 1.07 | 0.96, 1.19 | 1.11 | 1.00, 1.24* |
M0 + Reproductive history | 1.11 | 0.98, 1.27 | 1 | 1.06 | 0.97, 1.15 | 1.07 | 0.97, 1.19 | 1.12 | 1.01, 1.25 |
M0 + All risk factorsc | 0.99 | 0.87, 1.14 | 1 | 1.01 | 0.92, 1.10 | 1.01 | 0.91, 1.12 | 1.03 | 0.92, 1.15 |
Premenopausal women | |||||||||
Model 0: Stratified for age and centera | 1.33 | 1.04, 1.69 | 1 | 1.09 | 0.90, 1.33 | 1.22 | 1.01, 1.49 | 1.24 | 1.02, 1.51 |
M0 + Parity | 1.30 | 1.02, 1.66 | 1 | 1.08 | 0.89, 1.31 | 1.21 | 0.99, 1.47 | 1.22 | 1.00, 1.48 |
M0 + Age at first full term pregnancy | 1.11 | 0.86, 1.44 | 1 | 1.04 | 0.86, 1.27 | 1.13 | 0.92, 1.38 | 1.09 | 0.89, 1.34 |
M0 + Reproductive history | 1.14 | 0.88, 1.47 | 1 | 1.05 | 0.86, 1.28 | 1.14 | 0.93, 1.39 | 1.11 | 0.91, 1.36 |
M0 + All risk factorse | 1.00 | 0.77, 1.30 | 1 | 1.01 | 0.83, 1.23 | 1.06 | 0.87, 1.30 | 1.01 | 0.81, 1.24 |
Postmenopausal women | |||||||||
Model 0: Stratified for age and centera | 1.21 | 1.03, 1.41 | 1 | 1.09 | 0.98, 1.20 | 1.08 | 0.94, 1.23 | 1.20 | 1.05, 1.37 |
M0 + Parity | 1.17 | 1.00*, 1.37 | 1 | 1.07 | 0.97, 1.19 | 1.06 | 0.93, 1.21 | 1.17 | 1.02, 1.33 |
M0 + Age at first full term pregnancy | 1.09 | 0.93, 1.29 | 1 | 1.05 | 0.95, 1.17 | 1.02 | 0.89, 1.17 | 1.11 | 0.97, 1.27 |
M0 + Reproductive history | 1.10 | 0.93, 1.29 | 1 | 1.05 | 0.95, 1.17 | 1.02 | 0.89, 1.17 | 1.11 | 0.97, 1.27 |
M0 + All risk factorsf | 0.95 | 0.80, 1.12 | 1 | 0.99 | 0.89, 1.10 | 0.94 | 0.82, 1.08 | 1.00 | 0.87, 1.15 |
CI confidence interval; HR hazard ratios; RII relative index of inequality;
1 included in the CI;
Model 0 controls for age at baseline (1-year age category) and center;
Reproductive history: variable combining parity and age at first full term pregnancy;
reproductive history, ever breast feeding, common risk factors g, ever use of hormonal replacement therapy, menopausal status&age at menopause combined;
common risk factors g, ever use of hormonal replacement therapy, menopausal status&age at menopause combined;
reproductive history, ever breast feeding, common risk factors g;
reproductive history, ever breast feeding, common risk factors g, ever use of hormonal replacement therapy, age at menopause;
Common risk factors: age at menarche, ever use of oral contraceptives, height, BMI, alcohol consumption, total physical activity.
In all women, the association between education and invasive breast cancer was similarly weakened when adjusting for age at first full term pregnancy alone or combined with parity. On the contrary, adjusting for parity alone reduced the estimates by very little. When adjusted for reproductive history (variable combining parity and age at first full term pregnancy), the RII did not reach statistical significance (RII=1.11: 0.98, 1.25) and the HRs remained slightly greater than 1. Similar decreases were found in stratified analyses (parous, pre and postmenopausal women).
Once the largest impact on risks of adjustment for reproductive history was reached, further adjusting for each other risk factor separately did not change or only slightly reduced the HR or the RII (table 4). A substantial larger decrease was nevertheless observed when additionally adjusting for height, although the confidence intervals remained wide. Similar findings were observed in stratified analyses (results not shown).
Table 4.
Education | Primary | Vocational secondary | Other secondary | University or post-secondary vocational | |||||
---|---|---|---|---|---|---|---|---|---|
Model adjusted for | HR | HR | 95% CI | HR | 95% CI | HR | 95% CI | RII | 95% CI |
Model 0: Stratified for age and center a | 1 | 1.09 | 1.01, 1.18 | 1.12 | 1.02, 1.23 | 1.19 | 1.08, 1.31 | 1.22 | 1.09, 1.37 |
Model 1: Model 0 + reproductive historyb | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.18 | 1.10 | 1.00, 1.21 | 1.11 | 0.98, 1.25 |
Model 1 + age at menarche | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.17 | 1.10 | 1.00, 1.21* | 1.10 | 0.98, 1.24 |
Model 1 + ever breastfeeding | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.18 | 1.10 | 1.00, 1.22 | 1.11 | 0.98, 1.25 |
Model 1 + duration of breastfeading | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.18 | 1.10 | 1.00, 1.21* | 1.10 | 0.98, 1.25 |
Model 1 + ever use of HRT | 1 | 1.05 | 0.97, 1.14 | 1.06 | 0.96, 1.16 | 1.09 | 0.99, 1.20 | 1.09 | 0.97, 1.23 |
Model 1 + ever use of oral contraceptive | 1 | 1.06 | 0.98, 1.15 | 1.06 | 0.97, 1.17 | 1.09 | 0.99, 1.21 | 1.10 | 0.97, 1.24 |
Model 1 + duration of use of oral contraceptive | 1 | 1.06 | 0.98, 1.15 | 1.06 | 0.96, 1.17 | 1.09 | 0.99, 1.21 | 1.09 | 0.97, 1.23 |
Model 1 + duration of use of HRT | 1 | 1.05 | 0.97, 1.14 | 1.06 | 0.96, 1.16 | 1.09 | 0.99, 1.20 | 1.09 | 0.97, 1.23 |
Model 1 + alcohol consumption | 1 | 1.06 | 0.97, 1.15 | 1.06 | 0.96, 1.16 | 1.08 | 0.98, 1.19 | 1.08 | 0.96, 1.22 |
Model 1 + menopausal status | 1 | 1.06 | 0.98, 1.15 | 1.07 | 0.97, 1.18 | 1.10 | 1.00, 1.21* | 1.10 | 0.98, 1.24 |
Model 1 + age at menopause | 1 | 1.06 | 0.97, 1.15 | 1.06 | 0.96, 1.17 | 1.09 | 0.99, 1.20 | 1.09 | 0.97, 1.23 |
Model 1 + height | 1 | 1.04 | 0.96, 1.13 | 1.04 | 0.94, 1.14 | 1.06 | 0.96, 1.17 | 1.05 | 0.93, 1.18 |
Model 1 + BMI | 1 | 1.07 | 0.98, 1.16 | 1.07 | 0.98, 1.18 | 1.11 | 1.01, 1.22 | 1.11 | 0.99, 1.26 |
Model 1 + total physical activity | 1 | 1.05 | 0.97, 1.14 | 1.05 | 0.96, 1.16 | 1.08 | 0.98, 1.19 | 1.08 | 0.95, 1.22 |
Model adjusted for all risk factorsc | 1 | 1.01 | 0.93, 1.10 | 1.00 | 0.91, 1.11 | 1.01 | 0.91, 1.12 | 0.99 | 0.87, 1.12 |
BMI body mass index; CI confidence interval; HR hazard ratio; HRT hormonal replacement therapy; RII relative index of inequality;
1 included in the CI;
Model 0 controls for age at baseline (1-year age category) and center;
Reproductive history: variable combining parity and age at first full term pregnancy;
reproductive history, ever breast feeding, age at menarche, ever use of HRT and oral contraceptives, alcohol consumption, menopausal status&age at menopause combined, height, BMI, total physical activity
When all risk factors were adjusted for simultaneously, whether using categorical risks or RII, no association remained between education and invasive breast cancer risk both among all women (RII=0.99: 0.87, 1.12) and in stratified analyses (Table 3).
Inequalities in breast cancer incidence were more pronounced for in situ breast cancers (table 5). The HRs were particularly elevated among the highest educated women (university or post-secondary vocational education) when compared with the least educated women (primary education or less) (HR=1.57: 1.18, 2.08). After adjustment for all risk factors, inequalities in breast cancer incidence became statistically nonsignificant among parous women and completely disappeared only among postmenopausal women. In this group, the HR was statistically significantly below unity among women with vocational education when compared with women with primary education or less. Although based on small numbers, the fully adjusted risk estimates remained particularly elevated among nulliparous (RII=4.53: 1.50, 13.7) and premenopausal women (RII=2.72: 1.15, 6.44).
Table 5.
Model adjusted for | RII | 95% CI | Primary | Vocational secondary | Other secondary | University or post-secondary vocational | |||
---|---|---|---|---|---|---|---|---|---|
HR | HR | 95% CI | HR | 95% CI | HR | 95% CI | |||
All women | |||||||||
Model 0: Stratified for age and center a | 1.86 | 1.28, 2.70 | 1 | 0.94 | 0.71, 1.24 | 1.24 | 0.91, 1.70 | 1.57 | 1.18, 2.08 |
Model 0 + Reproductive historyb | 1.70 | 1.15, 2.51 | 1 | 0.92 | 0.69, 1.21 | 1.20 | 0.87, 1.65 | 1.47 | 1.10, 1.97 |
Model 0 + All risk factorsc | 1.61 | 1.07, 2.41 | 1 | 0.89 | 0.67, 1.18 | 1.15 | 0.83, 1.59 | 1.40 | 1.03, 1.90 |
Nulliparous women | |||||||||
Model 0: Stratified for age and center a | 3.92 | 1.38, 11.1 | 1 | 1.46 | 0.48, 2.78 | 1.39 | 0.53, 3.63 | 2.55 | 1.17, 5.55 |
Model 0 + All risk factorsd | 4.53 | 1.50, 13.7 | 1 | 1.08 | 0.44, 2.64 | 1.45 | 0.54, 3.86 | 2.68 | 1.18, 6.08 |
Parous women | |||||||||
Model 0: Stratified for age and center a | 1.68 | 1.11, 2.53 | 1 | 0.93 | 0.69, 1.24 | 1.28 | 0.92, 1.79 | 1.44 | 1.05, 1.97 |
Model 0 + Reproductive history | 1.52 | 0.99, 2.32 | 1 | 0.90 | 0.67, 1.22 | 1.23 | 0.87, 1.72 | 1.33 | 0.96, 1.84 |
Model 0 + All risk factorsc | 1.39 | 0.89, 2.17 | 1 | 0.87 | 0.64, 1.17 | 1.16 | 0.82, 1.64 | 1.25 | 0.89, 1.75 |
Premenopausal women | |||||||||
Model 0: Stratified for age and center a | 2.98 | 1.37, 6.47 | 1 | 1.97 | 1.03, 3.78 | 1.89 | 0.96, 3.71 | 2.70 | 1.46, 4.98 |
Model 0 + Reproductive history | 2.92 | 1.28, 6.68 | 1 | 1.98 | 1.02, 3.81 | 1.92 | 0.97, 3.82 | 2.68 | 1.41, 5.10 |
Model 0 + All risk factorse | 2.68 | 1.13, 6.34 | 1 | 1.90 | 0.97, 3.71 | 1.90 | 0.94, 3.83 | 2.51 | 1.28, 4.93 |
Postmenopausal women | |||||||||
Model 0: Stratified for age and center a | 1.26 | 0.76, 2.10 | 1 | 0.70 | 0.49, 1.00 | 1.14 | 0.76, 1.71 | 1.16 | 0.78, 1.71 |
Model 0 + Reproductive history | 1.09 | 0.65, 1.84 | 1 | 0.67 | 0.47, 0.96 | 1.05 | 0.70, 1.59 | 1.03 | 0.69, 1.55 |
Model 0 + All risk factorsf | 0.94 | 0.55, 1.64 | 1 | 0.62 | 0.43, 0.90 | 0.96 | 0.63, 1.46 | 0.93 | 0.61, 1.42 |
CI confidence interval; HR hazard ratio; RII relative index of inequality;
Model 0 controls for age at baseline (1-year age category) and center;
Reproductive history: variable combining parity and age at first full term pregnancy;
reproductive history, ever breast feeding, common risk factors g, ever use of hormonal replacement therapy, menopausal status&age at menopause combined;
common risk factors g, ever use of hormonal replacement therapy, menopausal status&age at menopause combined;
reproductive history, ever breast feeding, common risk factors g;
reproductive history, ever breast feeding, common risk factors g, ever use of hormonal replacement therapy, age at menopause;
Common risk factors: age at menarche, ever use of oral contraceptives, height, BMI, alcohol consumption, total physical activity.
We performed a heterogeneity analysis by country. Heterogeneity was observed for in situ breast cancers (p=0.02) but was not reported for invasive breast cancers (p=0.52). More precisely, the estimates in Greek centres differed from the overall estimate both for invasive and in situ breast cancers. For in situ breast cancers, Spanish, and to a lesser extent German centres, also differed from the overall estimate. In these centres, inequalities in breast cancer incidence were larger than overall.
DISCUSSION
Highly educated women have a higher breast cancer risk than women with a lower education. We investigated the role of numerous risk factors in explaining educational inequalities in breast cancer incidence. Reproductive history, especially age at first full term pregnancy, partly accounted for these inequalities. Among the other risk factors, height seemed to play a relatively important role. When all breast cancer risk factors were adjusted for, no association remained between education and invasive breast cancer risk whereas substantial inequalities in cancer incidence were still found for in situ breast cancers.
Limitations of the data
The study presents several strengths among which the longitudinal design, the large sample size, and the detailed information on many risk factors. However, some limitations should be addressed. First, we excluded women with missing education information. The risk of breast cancer in this group was similar to that observed among the highest educational group. However, as we do not know how these women are distributed by education, it is not possible to estimate how much the exclusion of these women influenced the estimates. Second, we conducted many simultaneous tests and therefore we cannot rule out that some of the statistically significant effects are due to chance. However, the larger decrease in breast cancer inequalities observed when adjusting for height was also reported in the scarce literature on this issue.
Then, although we adjusted for a large set of risk factors, genetic factors were not accounted for. Genetic mutations in alleles BRCA1 or BRCA2 have been identified as breast cancer risk factors [8]. These mutations could be acquired but are often inherited. Consequently, adjusting for breast cancer history among relatives indirectly accounts for this risk factor. This information was collected in few centres only and was thus not adjusted for in our analyses. However, further analyses restricted to these centres with additional control for family breast cancer history did not suggest an important contribution of this factor to socioeconomic inequalities in breast cancer risk. The population attributable fraction of family history to breast cancer is modest [10, 18]. Thus, the role of this risk factor in socioeconomic inequalities in breast cancer incidence is likely to be small.
Finally, differential attendance to screening was not accounted for but is likely to have induced higher incidence rates among higher educated women. Indeed, routine mammography is more frequently done among higher educated women [19–21]. Educational differences in breast cancer incidence would therefore be further reduced when adjusting for screening. To assess the potential impact of screening on educational differences in breast cancer incidence, we conducted analyses for in situ and invasive cancers separately. Also, as screening and case ascertainment practices differ between countries, which may induce differences between countries in socioeconomic inequalities in breast cancer incidence, we conducted heterogeneity analyses. Even though adjusting for screening uptake might reduce educational differences in incidence for all breast cancers, these analyses suggest that this would be more so for in situ cancers as discussed below.
We found larger inequalities for in situ breast cancers than for invasive breast cancers, as reported elsewhere [13]. Moreover, once adjusted for all risk factors, we still observed substantial educational inequalities for in situ breast cancers. The lower statistical power due to small number of in situ cases may have contributed to these differential findings. However, differential screening participation rates may also partly account for this finding. In situ tumours are indeed more likely than invasive tumours to be detected by routine mammography [12], which is more frequently done in higher educated women. In stratified analyses, inequalities for in situ breast cancers were more pronounced among nulliparous and premenopausal women. It is also likely that mammography use is more socially stratified among premenopausal women, as most of them have not yet reached the age-range for mass screening. Opportunistic screening is therefore certainly more frequent in this group than among postmenopausal women and larger socioeconomic inequalities have been found for opportunistic screening than for mass screening [20, 22]. However, the similarity of risk estimates by menopausal status even after adjusting for known risk factors does not support a strong confounding effect of screening. Lower attendance rates to organized screening programs are observed among women living without partner [23–25] and among nulliparous women [25]. As a consequence, in this group too, there might be more opportunistic screening and therefore large inequalities in screening use.
Cases were identified by active follow-up in Greece and Germany. In addition, not all the cancer registries involved in EPIC included screening programs as sources for breast cancer cases [26]. Moreover, educational inequalities in the utilization of mammography screening differed between countries. Inequalities seemed to be smaller in countries with long-sustained countrywide programs (as Sweden or the Netherlands) when compared with countries with recent and/or regional programs (as Italy or Spain) or opportunistic screening (as Greece or Germany) (Stirbu et al, submitted). Heterogeneity between countries was observed only for in situ breast cancers, and the estimates in Greece (for both invasive and in situ cancers), Spain, and Germany (for in situ cancers) were larger than the overall estimate. These findings may be partly explained by the method used in Greece for case identification. Moreover, these results are consistent with a role of screening in educational inequalities for in situ breast cancer incidence, as heterogeneity between countries was limited to these cancers.
Explanations of the key results
Adjusting for reproductive history (age at first full term pregnancy and parity) substantially reduced the association between education and breast cancer risk in our study. The RII decreased by 50% from 1.22 to 1.11, a percentage similar to what is reported in the literature [5, 7]. Age at first full term pregnancy rather than parity was the more relevant factor in explaining socioeconomic inequalities in breast cancer incidence, confirming previous findings [7]. This result may be explained by the stronger association with breast cancer incidence [8] combined with larger educational disparities observed for age at first full term pregnancy than for parity.
One previous study also reported an important contribution of height to inequalities in breast cancer incidence [4]. Height has been shown to be positively associated with the individual’s socioeconomic position, such as education, occupational class, workplace success or income [27–29]. This association remains partly unexplained but several factors related to childhood (health, socioeconomic position or diet) are likely to be implied. In addition, the discrimination hypothesis has been suggested: discrimination against short stature would prevent small people to get a high education or a high social position [30]. Height may be associated with breast cancer incidence through several pathways. Height might reflect mammary gland mass, which could be related to breast cancer risk [31]. It is also possible that genetic factors and environmental factors in childhood such as diet or physical activity may affect both attained height and hormonal factors (especially growth hormones), the latter leading to an increased risk of breast cancer [29, 32]. In addition, height might also be a marker of the socioeconomic position, including aspects that are not accounted for by education, and thus a marker of other breast cancer risk factors. Further studies are needed to explore the role of specific factors indicated by height in explaining socioeconomic inequalities in breast cancer incidence.
Controversial results are reported in the literature with regards to the level of socioeconomic inequalities in breast cancer incidence by menopausal status, with a steeper increase in breast cancer risk by educational level reported after menopause [5] or before menopause [10] as in our study. When interpreting these results, it is particularly difficult to disentangle the effect of menopause from the effect of birth cohort. The differences in inequalities in breast cancer incidence between pre- and postmenopausal women may actually be partly explained by factors that differ by birth cohort, such as age at first full term pregnancy [33]. Our results do support this hypothesis: the RIIs by menopausal status were quite similar once educational differences in age at first full term pregnancy were accounted for.
We used education as a measure of the socioeconomic position. Education is a suitable measure when investigating socioeconomic inequalities in health among women as this information is available for all women, including older women or housewives [34]. Also, education is quite easily and accurately recorded and it is unaffected by poor health in adulthood. Higher education may be associated with health through different pathways subjects with higher education may be more receptive to prevention messages and may have a better ability to change their health behaviour and to better use the health care system [34, 35]. A similar association between the socioeconomic position and breast cancer risk is also reported using other indicators. The more commonly used are income or occupational class, which measure different dimensions of the socioeconomic position [1, 36, 37]. Future studies are needed to assess whether similar patterns are observed when using such other indicators of the socioeconomic position, and especially those that capture more material dimensions of the socioeconomic position, such as income and wealth.
Contrary to most other cancer sites, breast cancer incidence shows a specific pattern with higher incidence rates among women with high socioeconomic position. This exceptional association calls for understanding. This study documented the relevant factors that explain this association with more precision and detail than any previous study. Age at first full term pregnancy, parity and height were the three main factors that accounted for nearly all educational differences in breast cancer incidence. In addition, this study was among the first to document that these inequalities were particularly pronounced for in situ breast cancer incidence. These inequalities could not be fully explained by known risk factors. We believe that a differential earlier detection bias may explain this result.
Acknowledgments
National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands (Gwenn Menvielle, Hendriek Boshuizen, Anne May, H Bas Bueno-de-Mesquita); INSERM U1018, CESP, Epidemiology of occupational and social determinants of health, Villejuif, France (Gwenn Menvielle); University of Versailles-Saint Quentin, UMRS 1018, France (Gwenn Menvielle); Erasmus Medical Center, Rotterdam, Netherlands (Gwenn Menvielle, Anton Kunst); Julius Centrum for Health Sciences and Primary Care, University Medical Center, Utrecht, Netherlands (Carla H van Gils, Petra H Peeters, Anne May, Evelyn Monninkhof); Dept of Epidemiology and Public Health, Imperial College, London, UK (Petra H Peeters, Valentina Gallo, Paolo Vineis, Elio Riboli); Department of Cardiology and Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark (Kim Overvad); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (Anja Olsen, Anne Tjonneland); Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (Silke Hermann, Rudolf Kaaks); German Institute of Human Nutrition Postdam-Rehbrücke, Germany (Manuela M Bergmann, Anne-Kathrin Illner); Dept of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece (Pagona Lagiou, Antonia Trichopoulou); Dpt of Epidemiology, Harvard School of Public Health, Boston, MA, USA (Dimitrios Trichopoulos); Hellenic Health Foundation, Athens, Greece (Dimitrios Trichopoulos); Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy (Domenico Palli); Department of Predictive Medicine and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (Franco Berrino); Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy (Amalia Mattielo); Cancer Registry and Histopathology Unit, “Civile M.P. Arezzo” hospital, ASP 7 Ragusa, Italy (Rosario Tumino); CPO-Piemonte, Torino, Italy (Carlotta Sacerdote); Institute of Community Medicine, University of Tromso, Norway (Tonje Braaten, Eiliv Lund); Public Health and Planification Directorate, Asturias, Spain (José Ramón Quirós); Unit of Nutrition, Environment, and Cancer, Catalan Institute of Oncology, Barcelona, Spain (Eric J Duell); Andalusian School of Public Health, Granada, Spain (Maria-José Sánchez); CIBER Epidemiología y Salud Pública (CIBERESP), Spain (Maria-José Sánchez, Carmen Navarro, Eva Ardanaz); Epidemiology Department, Murcia Health Council, Murcia, Spain (Carmen Navarro); Public Health Institute of Navarra, Pamplona, Spain (Eva Ardanaz); Department of Oncology, Lund University Hospital, Lund University, Lund, Sweden (Signe Borgquist); Department of Surgery, Malmö University Hospital, Lund University, Malmö, Sweden (Jonas Manjer); MRC Center for Nutritional Epidemiology and Cancer Prevention and Survival, Dept of Public Health and Primary Care, University of Cambridge, Cambridge, UK (Kay Tee Khaw); Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK (Naomi E Allen, Gillian K Reeves); International Agency for Research on Cancer, Lyon, France (Véronique Chajes, Sabina Rinaldi, Nadia Slimani); ISI Foundation, Torino, Italy (Paolo Vineis)
G Menvielle received a funding from the Fondation pour la Recherche Médicale for this analysis. The project was in part funded by the European Commission, through the Eurocadet project (from the commission of the European communities research directorate-general, grant No EUROCADET:SP23-CT-2005-006528). EPIC was supported by the European Commission: Public Health and Consumer Protection Directorate 1993–2004 and the Research Directorate-General 2005–2008.
European Commission FP5 project (QLG1-CT-2001-01049). The EPIC study was funded by “Europe Against Cancer” Programme of the European Commission (SANCO); Ligue contre le Cancer (France); Société 3M (France); Mutuelle Générale de l’Education Nationale; Institut National de la Santé et de la Recherche Médicale; German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Red Temática de Investigación Cooperativa de Centros de Cáncer (C03/10); the participating regional governments and institutions of Murcia, Navarra, Asturias, Pais Vasco y Andalucia, Spain; Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; The Wellcome Trust, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch Zorg Onderzoek Nederland; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten and Skane, Sweden; Norwegian Cancer Society; and Foundation to Promote Research into Functional Vitamin B12 Deficiency, Norway. Some authors are partners of Environmental Cancer Risk, Nutrition and Individual Susceptibility, a network of excellence of the European Commission (6FP contract 513943). Antonio Agudo and Paolo Vineis were supported by ECNIS.
Abbreviations
- RII
Relative Index of Inequality
- HR
Hazard Ratio
- BMI
body mass index
- HRT
hormonal replacement therapy
- EPIC
European Prospective Investigation into Cancer and Nutrition
References
- 1.Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ. 1997;138:65–176. [PubMed] [Google Scholar]
- 2.Bauman AE, Sallis JF, Dzewaltowski DA, Owen N. Toward a better understanding of the influences on physical activity: the role of determinants, correlates, causal variables, mediators, moderators, and confounders. Am J Prev Med. 2002 Aug;23(2 Suppl):5–14. doi: 10.1016/s0749-3797(02)00469-5. [DOI] [PubMed] [Google Scholar]
- 3.Dano H, Hansen KD, Jensen P, et al. Fertility pattern does not explain social gradient in breast cancer in denmark. Int J Cancer. 2004;111(3):451–56. doi: 10.1002/ijc.20203. [DOI] [PubMed] [Google Scholar]
- 4.Heck KE, Pamuk ER. Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol. 1997;145(4):366–72. doi: 10.1093/oxfordjournals.aje.a009114. [DOI] [PubMed] [Google Scholar]
- 5.Braaten T, Weiderpass E, Kumle M, Adami HO, Lund E. Education and risk of breast cancer in the Norwegian-Swedish women’s lifestyle and health cohort study. Int J Cancer. 2004;110(4):579–83. doi: 10.1002/ijc.20141. [DOI] [PubMed] [Google Scholar]
- 6.Braaten T, Weiderpass E, Kumle M, Lund E. Explaining the socioeconomic variation in cancer risk in the Norwegian Women and Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2591–7. doi: 10.1158/1055-9965.EPI-05-0345. [DOI] [PubMed] [Google Scholar]
- 7.Strand BH, Tverdal A, Claussen B, Zahl PH. Is birth history the key to highly educated women’s higher breast cancer mortality? A follow-up study of 500,000 women aged 35–54. Int J Cancer. 2005 Dec 20;117(6):1002–6. doi: 10.1002/ijc.21239. [DOI] [PubMed] [Google Scholar]
- 8.Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213–18. doi: 10.1186/bcr921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet. 1995;346(8979):883–87. doi: 10.1016/s0140-6736(95)92713-1. [DOI] [PubMed] [Google Scholar]
- 10.Tavani A, Braga C, La Vecchia C, Negri E, Russo A, Franceschi S. Attributable risks for breast cancer in Italy: education, family history and reproductive and hormonal factors. Int J Cancer. 1997 Jan 17;70(2):159–63. doi: 10.1002/(sici)1097-0215(19970117)70:2<159::aid-ijc4>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
- 11.Clavel-Chapelon F. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer. 2002;86(5):723–27. doi: 10.1038/sj.bjc.6600124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK. Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):961–5. [PubMed] [Google Scholar]
- 13.Hussain SK, Altieri A, Sundquist J, Hemminki K. Influence of education level on breast cancer risk and survival in Sweden between 1990 and 2004. Int J Cancer. 2008 Jan 1;122(1):165–9. doi: 10.1002/ijc.23007. [DOI] [PubMed] [Google Scholar]
- 14.Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26( Suppl 1):S6–14. doi: 10.1093/ije/26.suppl_1.s6. [DOI] [PubMed] [Google Scholar]
- 15.Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24. doi: 10.1079/PHN2002394. [DOI] [PubMed] [Google Scholar]
- 16.Mackenbach JP, Kunst AE. Measuring the magnitude of socio-economic inequalities in health: an overview of available measures illustrated with two examples from Europe. Soc Sci Med. 1997;44(6):757–71. doi: 10.1016/s0277-9536(96)00073-1. [DOI] [PubMed] [Google Scholar]
- 17.Johnsen NF, Tjonneland A, Thomsen BL, et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 2009 Aug 15;125(4):902–8. doi: 10.1002/ijc.24326. [DOI] [PubMed] [Google Scholar]
- 18.Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1638–44. [PubMed] [Google Scholar]
- 19.Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272(7):530–34. [PubMed] [Google Scholar]
- 20.Duport N, Ancelle-Park R, Boussac-Zarebska M, Uhry Z, Bloch J. Are breast cancer screening practices associated with sociodemographic status and healthcare access? Analysis of a French cross-sectional study. Eur J Cancer Prev. 2008 Jun;17(3):218–24. doi: 10.1097/CEJ.0b013e3282b6fde5. [DOI] [PubMed] [Google Scholar]
- 21.Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006 Jan;17(1):5–19. doi: 10.1093/annonc/mdj007. [DOI] [PubMed] [Google Scholar]
- 22.Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat. 2001 Nov;70(2):145–53. doi: 10.1023/a:1012939228916. [DOI] [PubMed] [Google Scholar]
- 23.Duport N, Ancelle-Park R. Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev. 2006 Jun;15(3):219–24. doi: 10.1097/01.cej.0000198902.78420.de. [DOI] [PubMed] [Google Scholar]
- 24.von Euler-Chelpin M, Olsen AH, Njor S, et al. Does educational level determine screening participation? Eur J Cancer Prev. 2008 Jun;17(3):273–8. doi: 10.1097/CEJ.0b013e3282f0c017. [DOI] [PubMed] [Google Scholar]
- 25.Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening--a population-based register study (Sweden) Cancer Causes Control. 2002 Feb;13(1):73–82. doi: 10.1023/a:1013978421073. [DOI] [PubMed] [Google Scholar]
- 26.International Agency for Research on Cancer. Cancer Incidence in 5 continents. Lyon: IARC; 2005. pp. I–VIII. [Google Scholar]
- 27.Cavelaars AE, Kunst AE, Geurts JJ, et al. Persistent variations in average height between countries and between socio-economic groups: an overview of 10 European countries. Ann Hum Biol. 2000 Jul-Aug;27(4):407–21. doi: 10.1080/03014460050044883. [DOI] [PubMed] [Google Scholar]
- 28.Silventoinen K, Lahelma E, Rahkonen O. Social background, adult body-height and health. Int J Epidemiol. 1999 Oct;28(5):911–8. doi: 10.1093/ije/28.5.911. [DOI] [PubMed] [Google Scholar]
- 29.Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23(2):313–42. doi: 10.1093/oxfordjournals.epirev.a000809. [DOI] [PubMed] [Google Scholar]
- 30.Magnusson PK, Rasmussen F, Gyllensten UB. Height at age 18 years is a strong predictor of attained education later in life: cohort study of over 950,000 Swedish men. Int J Epidemiol. 2006 Jun;35(3):658–63. doi: 10.1093/ije/dyl011. [DOI] [PubMed] [Google Scholar]
- 31.Trichopoulos D, Lipman RD. Mammary gland mass and breast cancer risk. Epidemiology. 1992 Nov;3(6):523–6. doi: 10.1097/00001648-199211000-00011. [DOI] [PubMed] [Google Scholar]
- 32.van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000 Sep 15;152(6):514–27. doi: 10.1093/aje/152.6.514. [DOI] [PubMed] [Google Scholar]
- 33.Rendall M, Couet C, Lappegard T, Robert-Bobee I, Ronsen M, Smallwood S. First births by age and education in Britain, France and Norway. Popul Trends. 2005 Autumn;(121):27–34. [PubMed] [Google Scholar]
- 34.Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1) J Epidemiol Community Health. 2006 Jan;60(1):7–12. doi: 10.1136/jech.2004.023531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Berkman LF, Macintyre S. The measurement of social class in health studies:old measures and new formulations. IARC Sci Publ. 1997;138:51–64. [PubMed] [Google Scholar]
- 36.Carlsen K, Hoybye M, Dalton S, Tjonneland A. Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008 Sep;44(14):1996–2002. doi: 10.1016/j.ejca.2008.06.027. [DOI] [PubMed] [Google Scholar]
- 37.Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20:417–35. doi: 10.1007/s10552-008-9256-0. [DOI] [PMC free article] [PubMed] [Google Scholar]